Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE penicillin allergy perioperative de-labelling trial
ACTRN12620001295932Phase 2Completed
- Sponsor
- Austin Health
- Start
- Feb 2021
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of phenoxymethylpenicillin, amoxicillin and cefalexin in penicillin allergy, cephalosporin allergy and Antibiotic allergy, sponsored by Austin Health. Primary endpoints: Feasibility of intervention delivery, Feasibility of recruitment and 1 more. Started Feb 2021; status: completed.
02
Drugs
phenoxymethylpenicillinamoxicillincefalexin
03
Conditions
penicillin allergycephalosporin allergyAntibiotic allergy
Beyond the preview
Go deeper on ACTRN12620001295932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001295932.